fashion -WSS

fashion

author：comprehensive 2025-09-27 10:03:52 - browse：38

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How dance can help health care workers heal from trauma

hotspot

WSS

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Lindsay Lohan welcomes 1st child with husband Bader Shammas

CRISPR gene editing developments we’re watching in 2024

Ebola public health emergency is over, WHO declares

explore

fashion

leisure time

Moonlake's readout produced a cash windfall. Risks remain

Stanford president to resign after investigation of research

Hollywood unions extend contract negotiations for actors

The kidney, in all its complexity, is captured in a new atlas

Duchenne breakthrough therapy leaves behind pioneering families

Stanford updates investigation of president’s past research

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Medical records are filled with copy

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

knowledge

Hospitals owned by private equity see complications spike 25%

Editas, Vertex strike deal on CRISPR

New warning issued for rebooking air travel after delays, cancellations

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

SNAP should offer more nutrition education

Three trends to watch in biotech in 2024

focus

focus

hotspot

leisure time